Tevogen Inc. (TVGNW) stock
TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN
$0.09+0.01 (+18.24%)
Close on Oct 30, 2026Market cap $38.42MP/E –Yield –
Tevogen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tevogen's enterprise value was $27.72M on Oct 19, 2026, against $121.03M a year earlier. Over the last 3 years it ranged from $17.62M to $931.35M, with a median of $117.73M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $27.72M | -56.9% |
| 2025 | Dec 31, 2025 | $64.32M | -62.9% |
| 2024 | Dec 31, 2024 | $173.57M | +737.3% |
| 2023 | Apr 28, 2023 | $20.73M | – |